Structures by: Kovalenko S. S.
Total: 7
3-Cyclopropyl-5-(3-methyl-[1,2,4]triazolo[4,3-<i>a</i>]pyridin-7-yl)-1,2,4-oxadiazole
C12H11N5O
Acta Crystallographica Section C (2021) 77, 1
a=4.4041(4)Å b=27.8787(18)Å c=9.3533(8)Å
α=90° β=100.816(7)° γ=90°
3-Cyclopropyl-5-(3-methyl-[1,2,4]triazolo[4,3-<i>a</i>]pyridin-7-yl)-1,2,4-oxadiazole
C12H11N5O
Acta Crystallographica Section C (2021) 77, 1
a=12.2191(13)Å b=8.1593(9)Å c=22.788(2)Å
α=90° β=90° γ=90°
3-Cyclopropyl-5-(2-hydrazinylpyridin-3-yl)-1,2,4-oxadiazole
C10H11N5O
Acta Crystallographica Section C (2020) 76, 8
a=8.4476(10)Å b=8.5662(8)Å c=8.6125(8)Å
α=110.812(9)° β=115.048(11)° γ=92.854(9)°
3-Cyclopropyl-5-(2-hydrazinylpyridin-3-yl)-1,2,4-oxadiazole
C10H11N5O
Acta Crystallographica Section C (2020) 76, 8
a=4.8240(11)Å b=8.2685(19)Å c=26.527(10)Å
α=90° β=90° γ=90°
Ethyl 6-ethoxy-10-(3-methoxypropyl)-9-methyl-11-thioxo-8-oxa-10,12- diazatricyclo[7.3.1.0^2,7^]trideca-2,4,6-triene-13-carboxylate
C20H28N2O5S
Acta Crystallographica Section E (2007) 63, 12 o4906-o4906
a=9.7612(16)Å b=10.3405(17)Å c=12.309(2)Å
α=107.354(13)° β=109.709(13)° γ=100.096(12)°
5-[(3,4-Dimethylphenyl)sulfonyl]-8-methoxy-2-methyl-2,3,5,6-tetrahydro-4H- 2,6-methano-1,3-benzoxazocin-4-one
C21H23NO5S
Acta Crystallographica Section E (2007) 63, 12 o4845-o4845
a=8.077(4)Å b=11.153(6)Å c=11.724(6)Å
α=94.77(4)° β=106.22(4)° γ=98.36(4)°
1-(8-Bromo-2-methyl-4-thioxo-3,4,5,6-tetrahydro-2<i>H</i>-2,6-methano-1,3- benzoxazocin-11-yl)ethanone
C14H14BrNO2S
Acta Crystallographica Section E (2009) 65, 3 o461
a=8.213(5)Å b=11.625(7)Å c=15.156(10)Å
α=98.67(5)° β=99.09(5)° γ=101.81(5)°